• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 0.25%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    3.58 Down 0.26(6.77%) Jun 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.84
    Open:3.86
    Bid:3.43 x 300
    Ask:3.73 x 13000
    1y Target Est:7.00
    Beta:2.1
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:3.54 - 3.89
    52wk Range:1.94 - 5.48
    Volume:2,783,581
    Avg Vol (3m):1,932,550
    Market Cap:421.99M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IDRADown 6.77%421.99M
    DVAXDown 1.01%660.49M
    PFEDown 0.55%212.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4,352.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Jun-15) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback